aspartic acid has been researched along with alanosine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (76.92) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Graff, JC; Plagemann, PG | 1 |
| Adamson, RH; Anandaraj, S; Cooney, DA; Jayaram, HN; Kelley, JM | 1 |
| Chang, M; Creagan, ET; Cullinan, SA; Ebbert, L; Mailliard, JA; Morton, RF; Veeder, MH | 1 |
| Baillon, J; Hervé, G; Tauc, P | 1 |
| Assandri, A; Barone, D; Galliani, G; Grandi, M; Lancini, GC; Mistrello, G | 1 |
| Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J; Schutt, AJ | 1 |
| Creagan, ET; Kovach, JS; O'Connell, MJ | 1 |
| Cadman, E; Goldberg, D; Heimer, R | 1 |
| Koch, MR; Lea, MA | 1 |
| Anandaraj, SJ; Chitnis, M; Cooney, DA; Han, N; Jayaram, HN; Montgomery, JA; Thomas, JH; Tyagi, AK | 1 |
| Haigh, JR; Houben, K; Howard, BD; Ramachandran, B; Rozenberg, YY; Varpetian, A | 1 |
| Bonomo, J; Gill, RT; Lynch, MD; Price, JV; Warnecke, T | 1 |
| Daniel-Ivad, P; He, HY; Niikura, H; Ryan, KS; Wang, M | 1 |
2 trial(s) available for aspartic acid and alanosine
| Article | Year |
|---|---|
Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma.
Topics: Alanine; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cimetidine; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Phosphonoacetic Acid; Pleural Neoplasms; Soft Tissue Neoplasms | 1987 |
Clinical trial of PALA and L-Alanosine in advanced colorectal carcinoma.
Topics: Adult; Aged; Alanine; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Clinical Trials as Topic; Colonic Neoplasms; Female; Humans; Male; Middle Aged; Nausea; Phosphonoacetic Acid; Rectal Neoplasms; Stomatitis | 1983 |
11 other study(ies) available for aspartic acid and alanosine
| Article | Year |
|---|---|
Alanosine toxicity in Novikoff rat hepatoma cells due to inhibition of the conversion of inosine monophosphate to adenosine monophosphate.
Topics: Adenine; Adenosine Monophosphate; Adenosine Triphosphate; Alanine; Aspartic Acid; Carcinoma, Hepatocellular; Cell Division; Cell Line; Cells, Cultured; Depression, Chemical; DNA, Neoplasm; Glucose; Hypoxanthines; Inosine Nucleotides; Liver Neoplasms; Mengovirus; Neoplasm Proteins; Neoplasms, Experimental; Nitroso Compounds; Purine Nucleotides; Pyrimidine Nucleotides; RNA, Neoplasm; Succinates; Uracil Nucleotides; Uridine | 1976 |
Pharmacologic disposition of DL-alanosine in mice, rats, dogs, and monkeys.
Topics: Alanine; Animals; Antibiotics, Antineoplastic; Aspartic Acid; Carbon Dioxide; Cats; Cells, Cultured; Dogs; Female; Haplorhini; Intestine, Small; Kidney; Kinetics; Leukemia, Experimental; Liver; Lung; Male; Nitrosamines; Rats; Sodium; Temperature | 1977 |
L-alanosine: a noncooperative substrate for Escherichia coli aspartate transcarbamylase.
Topics: Alanine; Antibiotics, Antineoplastic; Aspartate Carbamoyltransferase; Aspartic Acid; Carbon Radioisotopes; Escherichia coli; Hydrogen-Ion Concentration; Kinetics; Molecular Conformation; Radioisotope Dilution Technique; Substrate Specificity | 1985 |
Contragestational profile of the tumor-inhibiting agent, L-alanosine, in the rat and the hamster.
Topics: Adenine; Alanine; Animals; Antibiotics, Antineoplastic; Aspartic Acid; Cell Division; Cricetinae; Dose-Response Relationship, Drug; Female; Fertility; Mesocricetus; Pregnancy; Rats; Rats, Inbred Strains; Time Factors | 1985 |
A Phase I study of the combination N-(phosphonacetyl)-L-aspartate (PALA, NSC-224131) and L-alanosine (NSC-153353) in patients with advanced cancer.
Topics: Alanine; Aspartic Acid; Diarrhea; Digestive System Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Humans; Injections, Intravenous; Organophosphorus Compounds; Phosphonoacetic Acid; Stomatitis | 1983 |
Modulation of fluoropyrimidine metabolism in L1210 cells by L-alanosine.
Topics: Adenine; Alanine; Animals; Aspartic Acid; Cells, Cultured; Clone Cells; Deoxyuridine; Leukemia L1210; Mice; Nucleotides; Pyrimidines; Time Factors | 1983 |
Uptake of 14C-labeled dicarboxylic amino acids in hepatocytes and hepatoma cells.
Topics: Alanine; Amino Acids; Amino Acids, Cyclic; Amino Acids, Dicarboxylic; Aminoisobutyric Acids; Animals; Antibiotics, Antineoplastic; Aspartic Acid; Liver; Liver Neoplasms, Experimental; Male; Nitrosamines; Phosphonoacetic Acid; Rats; Sodium | 1981 |
Interaction of L-alanosine (NSC 153, 353) with enzymes metabolizing L-aspartic acid, L-glutamic acid and their amides.
Topics: Adenosine Triphosphate; Alanine; Amino Acids; Animals; Antineoplastic Agents; Aspartic Acid; Biological Transport, Active; DNA; Glutamates; Inosine Monophosphate; Liver; Male; Mice; Nitrosamines | 1980 |
Differential expression of transporters for norepinephrine and glutamate in wild type, variant, and WNT1-expressing PC12 cells.
Topics: Alanine; Amino Acid Sequence; Amino Acid Transport System X-AG; Animals; Aspartic Acid; Biological Transport; Carrier Proteins; DNA, Complementary; Gene Expression; Glycine; Glycoproteins; Molecular Sequence Data; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Oncogene Proteins; PC12 Cells; Phosphonoacetic Acid; RNA, Messenger; Symporters | 1993 |
Genome-scale analysis of anti-metabolite directed strain engineering.
Topics: Alanine; Algorithms; Antimetabolites; Asparagine; Aspartic Acid; Cloning, Molecular; Contig Mapping; Escherichia coli; Gene Expression Profiling; Gene Frequency; Genetic Engineering; Genome, Bacterial; Genomic Library; Genomics; Lac Operon; Mutagenesis, Insertional; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Phenotype; Plasmids; Selection, Genetic | 2008 |
Biosynthesis of the N-N-Bond-Containing Compound l-Alanosine.
Topics: Alanine; Aspartic Acid; Glutamic Acid; Molecular Structure; Multigene Family; Streptomyces | 2020 |